Navigation Links
Living longer with obesity means heavier burden for hospitals
Date:12/10/2007

WEST LAFAYETTE, Ind. - Living longer with obesity can lead to both longer hospital stays and more avoidable trips to the hospital, according to two new studies from Purdue University.

"Americans are overweight, and there are numerous studies that cite the problems of obesity," said Ken Ferraro, a professor of sociology. "However, as the age at which people become obese continues to get younger, we wanted to know how living longer with obesity affects people.

"These findings could motivate young people to reverse the trend with healthy eating and activity and, if so, they may be able to avoid the consequences of chronic obesity."

Ferraro, along with graduate student Markus Schafer, studied how obesity influences hospitalizations by using 20 years of personal health data based on surveys linked to hospital records of more than 4,000 people ages 25-77. The data, from 1971-1992, was part of a federally funded national health and nutrition survey.

"In an economic sense, we have a major problem on our hands in terms of what we would project for today's overweight children and teenagers," said Ferraro, who is director of Purdue's Center on Aging and the Life Course. "In the past, people's weight peaked during late middle age. As more young people become obese, we may anticipate accumulated health problems by the time they are 40. If they are going to be obese for 30, 40 or 50 years, then the health-care costs associated with their adult medical needs will skyrocket. These findings are more evidence that we need to act now to reverse the obesity trend in our younger people. Although it is hard to project the future from these data, the likely scenarios portend a diabetes epidemic."

The study by Schafer and Ferraro examining the length of hospital stays appears in this month's Journal of Health and Social Behavior.

"Other research evaluating obesity and hospitalization has typically assessed short-term effects
'/>"/>

Contact: Amy Patterson Neubert
apatterson@purdue.edu
765-494-9723
Purdue University  
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. ADDAS Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them
2. Molecular probe paints cancer cells in living animals, Stanford researchers find
3. Scientists get first look at nanotubes inside living animals
4. Retirement Living TV Presents Sex, Drugs and Rock N Roll
5. CPF Living with IPF Patient Seminar to be Webcast Live October 13, 2007
6. Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter
7. National Energy Services Receives Repeat Orders From Golden Living and Cathedral Rock Skilled Nursing Facilities
8. Living Your Best Life: Adjusting Mind, Body and Spirit
9. How to Beat the High Cost of Living
10. Long Term Care Newsletter Debuts, Published by LTC Financial Partners; Advice on Living Better, Not Just Longer, With Financial Protection
11. A longer-living, healthier mouse that could hold clues to human aging
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Living longer with obesity means heavier burden for hospitals
Living longer with obesity means heavier burden for hospitals
Other Medicine Technology:Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 2Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 3Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 4Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 2Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 3Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 4Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 5Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 6